News
US stocks closed mixed on Monday, but the Nasdaq Composite and S&P 500 managed to notch fresh records. Wall Street began a ...
PepsiCo’s stock jumped 7% on July 17 after a robust Q2 earnings announcement. The company not only surpassed expectations but ...
Citigroup is the top-performing major bank stock this year with a gain of 33% and the advance is far from over, according to ...
Markets have already priced in the best-case scenario. Investors are in store for a pullback, Evercore's Julian Emanuel said.
Opendoor Technologies rose 25% in premarket trading after a social media post by Carvana spotter Eric Jackson. Tesla rose ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Intel is scheduled to report second-quarter results after the closing bell Thursday, with analysts tracked by Visible Alpha ...
The South Korean president’s push to cancel listed companies’ treasury stock purchases will strengthen corporate governance ...
Tariffs, tax credits, and consumer demand will all be on investors’ minds when General Motors kicks off automotive earnings ...
Most investors don’t see the drugmaker’s executive management as credible, following the failure to disclose a patient death, ...
Cleveland-Cliffs reports a per-share loss of 50 cents from sales of $4.9 billion. Wall Street was looking a per-share loss of ...
The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results